Hims to Sell Lilly’s Zepbound Through Telehealth Platform (1)

Hims & Hers Health Inc.’s shares rose Tuesday after it said it was broadening its weight-loss offerings, adding access to brand name shots like Zepbound after previously focusing on cheaper versions made by compounding pharmacies.

Hims shares gained 5.1% in New York on Tuesday.

Patients can now get a Zepbound prescription through Hims’ telehealth platform, a spokesperson said in an email. A monthly prescription for Zepbound will cost $1,899 a month, according to the company’s website. This is roughly $800 more than the list price Eli Lilly & Co. charges for its drug, and includes a Hims membership, unlimited consultations ...